Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
Dec 10
|
3 Unstoppable Stocks to Buy Right Now
|
Dec 7
|
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
|
Nov 27
|
11 Best Upside Stocks To Buy Right Now
|
Nov 7
|
Axsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates
|
Nov 7
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript
|
Nov 7
|
Q3 2023 Axsome Therapeutics Inc Earnings Call
|
Nov 6
|
Axsome Therapeutics Inc (AXSM) Reports 244% YoY Growth in 3Q 2023 Product Revenue
|
Nov 6
|
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
|
Nov 2
|
Axsome Therapeutics and the Global Alzheimer’s Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer’s Disease Awareness Month 2023
|
Oct 27
|
Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now
|
Oct 25
|
2 Biotech Stocks You Can Buy and Hold for the Next Decade
|
Oct 24
|
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
|
Sep 12
|
2 No-Brainer Biotech Stocks to Buy Right Now
|
Sep 7
|
Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
|
Aug 9
|
Axsome Therapeutics Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Aug 8
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2023 Earnings Call Transcript
|
Aug 8
|
DraftKings upgraded, Home Depot downgraded: Wall Street's top analyst calls
|
Aug 8
|
Axsome (AXSM) Q2 Earnings Beat, Stock Dips on Pipeline Updates
|
Aug 8
|
Q2 2023 Axsome Therapeutics Inc Earnings Call
|